MyFinsight
Home
Blog
About
Cash and cash
equivalents
$11,482,792
(121.94%↑ Y/Y)
Prepaid expenses and
other current assets
$201,724
(8.43%↑ Y/Y)
Total current assets
$11,684,516
(118.00%↑ Y/Y)
Operating lease
right-of-use asset
$610,443
Property and equipment,
net
$172,032
(389.14%↑ Y/Y)
Other assets
$30,941
Total assets
$12,497,932
(131.65%↑ Y/Y)
Total liabilities and
stockholders' equity
$12,497,932
(131.65%↑ Y/Y)
Total stockholders'
equity
$10,066,986
(163.14%↑ Y/Y)
Total liabilities
$2,430,946
(54.91%↑ Y/Y)
Accumulated deficit
-$55,751,722
(-23.89%↓ Y/Y)
Additional
paid-in-capital
$65,814,800
(34.80%↑ Y/Y)
Total current
liabilities
$1,880,400
(19.82%↑ Y/Y)
Operating lease
liability, net of current...
$550,546
Common stock, 0.001 par
value 500,000,000...
$3,908
(154.59%↑ Y/Y)
Accounts payable
$931,093
(12.33%↑ Y/Y)
Accrued expenses
$759,937
(2.75%↑ Y/Y)
Operating lease liability
$189,370
Back
Back
Balance Sheet
REVELATION BIOSCIENCES, INC. (REVBW)
REVELATION BIOSCIENCES, INC. (REVBW)
source: myfinsight.com